HEALTH NEWS

Study Title:

Resveratrol supplementation reduces ACE2 expression in human adipose tissue.

Study Abstract

Angiotensin converting enzyme-2 (ACE2) is the cell-surface receptor enabling cellular entry of SARS-CoV-2. ACE2 is highly expressed in adipose tissue (AT), rendering AT a potential SARS-CoV-2 reservoir contributing to massive viral spread in COVID-19 patients with obesity. Although rodent and cell studies suggest that the polyphenol resveratrol alters ACE2, human studies are lacking. Here, we investigated the effects of 30-days resveratrol supplementation on RAS components in AT and skeletal muscle in men with obesity in a placebo-controlled cross-over study. Resveratrol markedly decreased ACE2 (~40%) and leptin (~30%), but did neither alter angiotensinogen, ACE and AT1R expression in AT nor skeletal muscle RAS components. These findings demonstrate that resveratrol supplementation reduces ACE2 in AT, which might dampen SARS-CoV-2 spread in COVID-19.

Study Information

Adipocyte. 2021 Dec;10(1):408-411. doi: 10.1080/21623945.2021.1965315. PMID: 34402717; PMCID: PMC8381800.

Full Study

https://pubmed.ncbi.nlm.nih.gov/34402717/